Published in Front Microbiol on July 28, 2015
The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research. Antiviral Res (2009) 1.93
Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. J Neurovirol (2009) 1.75
DJ-1/PARK7 is an important mediator of hypoxia-induced cellular responses. Proc Natl Acad Sci U S A (2009) 1.71
Neurodegeneration and ageing in the HAART era. J Neuroimmune Pharmacol (2008) 1.70
Variable benefit in neuropsychological function in HIV-infected HAART-treated patients. Neurology (2006) 1.56
Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor. Neurotoxicology (2005) 1.51
Low atazanavir concentrations in cerebrospinal fluid. AIDS (2009) 1.45
Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: evidence for a role of the envelope. J Virol (1999) 1.40
Neurocognitive disturbances in HIV. Int Rev Psychiatry (2008) 1.38
Neurological complications of HIV infection. Lancet (1996) 1.38
Gap junctions mediate human immunodeficiency virus-bystander killing in astrocytes. J Neurosci (2007) 1.33
Neurocognition in individuals co-infected with HIV and hepatitis C. J Addict Dis (2008) 1.30
Mitochondria mass is low in mouse substantia nigra dopamine neurons: implications for Parkinson's disease. Exp Neurol (2006) 1.27
Cognitive performance related to HIV-1-infected monocytes. J Neuropsychiatry Clin Neurosci (2012) 1.26
Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson disease (PARK7). Hum Mutat (2004) 1.22
Parkinson's disease: animal models and dopaminergic cell vulnerability. Front Neuroanat (2014) 1.18
Interactive role of human immunodeficiency virus type 1 (HIV-1) clade-specific Tat protein and cocaine in blood-brain barrier dysfunction: implications for HIV-1-associated neurocognitive disorder. J Neurovirol (2010) 1.16
Neurocognitive effects of HIV, hepatitis C, and substance use history. J Int Neuropsychol Soc (2011) 1.15
Cocaine modulates dendritic cell-specific C type intercellular adhesion molecule-3-grabbing nonintegrin expression by dendritic cells in HIV-1 patients. J Immunol (2005) 1.11
Effects of alcohol on histone deacetylase 2 (HDAC2) and the neuroprotective role of trichostatin A (TSA). Alcohol Clin Exp Res (2011) 1.11
Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells. Int J Nanomedicine (2012) 1.08
Quantitative methods for assessing drug synergism. Genes Cancer (2011) 1.06
Etiology and pathogenesis of Parkinson disease. Neurol Clin (2009) 1.05
Human synaptic plasticity gene expression profile and dendritic spine density changes in HIV-infected human CNS cells: role in HIV-associated neurocognitive disorders (HAND). PLoS One (2013) 1.05
Vorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive disorder. Mol Brain (2014) 1.02
Parkinsonism in hiv-infected patients on highly active antiretroviral therapy. Neurology (2009) 1.00
Investigating cognitive genetics and its implications for the treatment of cognitive deficit. Genes Brain Behav (2006) 0.99
Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort. Arch Neurol (2008) 0.93
Ashwagandha (Withania somnifera) reverses β-amyloid1-42 induced toxicity in human neuronal cells: implications in HIV-associated neurocognitive disorders (HAND). PLoS One (2013) 0.93
Genetic basis of Parkinson's disease: inheritance, penetrance, and expression. Appl Clin Genet (2011) 0.90
HIV-1/cocaine induced oxidative stress disrupts tight junction protein-1 in human pulmonary microvascular endothelial cells: role of Ras/ERK1/2 pathway. PLoS One (2014) 0.87
Independent effects of HIV infection and cocaine dependence on neurocognitive impairment in a community sample living in the southern United States. Drug Alcohol Depend (2015) 0.86
A role for spermine oxidase as a mediator of reactive oxygen species production in HIV-Tat-induced neuronal toxicity. Free Radic Biol Med (2013) 0.86
A new possible mechanism of human immunodeficiency virus type 1 infection of neural cells. Neurobiol Dis (2002) 0.85
Human immunodeficiency virus-1 Tat protein increases the number of inhibitory synapses between hippocampal neurons in culture. J Neurosci (2013) 0.84
Involvement and interplay of Parkin, PINK1, and DJ1 in neurodegenerative and neuroinflammatory disorders. Free Radic Biol Med (2012) 0.83
Brain mitochondria from DJ-1 knockout mice show increased respiration-dependent hydrogen peroxide consumption. Redox Biol (2014) 0.81
Specific increase in MDR1 mediated drug-efflux in human brain endothelial cells following co-exposure to HIV-1 and saquinavir. PLoS One (2013) 0.81
Microvascular Endothelial Dysfunction and Enhanced Thromboxane and Endothelial Contractility in Patients with HIV. J AIDS Clin Res (2013) 0.79
DJ1 represses glycolysis and cell proliferation by transcriptionally up-regulating Pink1. Biochem J (2015) 0.78
PARK7 protein translocating into spermatozoa mitochondria in Chinese asthenozoospermia. Reproduction (2014) 0.76
Deep Brain Stimulation of the Subthalamic Nucleus for Parkinson's Disease in a Patient with HIV Infection: Dual Clinical Benefit. Case Rep Neurol (2011) 0.76